$11.96 +0.43 (3.73%)
NeOnc Technologies Holdings, Inc. Common Stock (NTHI)
NeOnc Technologies Holdings, Inc. is a healthcare-focused company specializing in the development and commercialization of innovative diagnostic and therapeutic solutions for cancer. The company aims to leverage advanced technologies to improve cancer detection and treatment, providing targeted options to enhance patient outcomes.
Company News
NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board
NeOnc Technologies has appointed renowned neuro-oncologist Dr. Henry S. Friedman to its scientific advisory board, strengthening its expertise in developing therapies for central nervous system cancers.